NDRG2 and breast cancer: Underlining the published functional consequences of NDRG2 re-expression in luminal type breast cancer we demonstrated a 26% decreased proliferation rate in NDRG2 over-expressing MCF7 compared to control cells while significance was barely missed (P = 0.064) (S3F Fig).